Treatment
Ropeginterferon alfa-2b clinical trials
We’re tracking 10 recruiting studies that include Ropeginterferon alfa-2b, each written for real people, not researchers, below.
Recruiting studies
- NCT05731245RecruitingPhase 2
Ropeginterferon for early myelofibrosis with low-to-mid risk
This Phase 2 trial studies ropeginterferon alfa-2b (a type of interferon medicine) in adults with early, lower-risk myelofibrosis. The goal is to see if it can control the disease better or improve outcomes with an acceptable safety profile.
Taipei, Taiwan, 100Ages 20 years+ - NCT07722611RecruitingPhase 2/Phase 3
Bomedemstat for polycythemia vera after hydroxyurea failure
This trial tests an experimental pill called bomedemstat for people with polycythemia vera who have not responded well to or could not tolerate hydroxyurea. It aims to see if the drug can help control red blood cell counts with fewer side effects.
JerusalemAges 18 years+ - NCT04655092RecruitingPhase 3
Extension study for people finishing prior P1101 treatment
This is an “extension” trial for people who already completed a 52-week P1101 study and agreed to continue. It tests whether continuing P1101 after the original study is safe and beneficial for certain patients.
Toon-shi, EhimeAges 20 years+ - NCT07646821RecruitingPhase 1/Phase 2
New drug combo for MDS or AML with TP53 gene changes
This trial tests a new combination of two drugs, ropeginterferon alfa-2b and azacitidine, for people with MDS or AML who have a change in the TP53 gene. The goal is to see if this combination can help control the disease and possibly improve outcomes.
Houston, TexasAges 18 years+ - NCT07521046RecruitingPhase 1
Adding interferon to ruxolitinib for myelofibrosis
This trial tests whether adding a drug called interferon alfa-2b to the standard treatment ruxolitinib can help people with myelofibrosis. It may reduce spleen size and improve blood counts.
Salt Lake City, UtahAges 18 years+ - NCT07269470RecruitingPhase 2
Dasatinib plus ropeginterferon for new CML
This trial tests a combination of two drugs, dasatinib and ropeginterferon, for people newly diagnosed with chronic myeloid leukemia (CML) in its early chronic phase. The goal is to see if the combination works safely and helps control the disease.
Houston, TexasAges 18 years+ - NCT07047885RecruitingPhase 1
Ropeginterferon for cutaneous T-cell lymphoma
This trial tests a medication called Ropeginterferon (a type of immune-supporting protein given as a shot) for people with different stages of cutaneous T-cell lymphoma. It may be an option if prior skin treatments haven't worked well enough.
Tampa, FloridaAges 18 years+ - NCT06770842RecruitingPhase 2
Study of two drugs for myelofibrosis with prior treatment
This trial tests a combination of two medications, ropeginterferon alfa-2b and ruxolitinib, for people with myelofibrosis whose spleen has not shrunk enough or has grown back while on ruxolitinib. The goal is to see if adding the newer drug can improve outcomes.
Hong KongAges 18 years+ - NCT06743035Recruiting
Study of ropeginterferon for polycythemia vera without enlarged spleen
This study is testing a medicine called ropeginterferon alfa-2b for people with polycythemia vera (a blood condition) who do not have a swollen spleen that causes symptoms. It looks at how well the medicine works and how it affects your daily life through simple questionnaires.
Hanover, Lower SaxonyAges 18 years+ - NCT06506084Recruiting
Study of ropeginterferon alfa-2b for polycythemia vera
This study looks at how well a drug called ropeginterferon alfa-2b works for people with polycythemia vera. It aims to understand the drug's effects and safety when used as a first or later treatment option.
Bergamo, LombardyAges 18–100
What Ropeginterferon alfa-2b is being studied for
Conditions with recruiting Ropeginterferon alfa-2b studies.
Common questions
- Are there clinical trials studying Ropeginterferon alfa-2b?
- Yes. Clin2 currently lists 10 recruiting studies that include Ropeginterferon alfa-2b, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Ropeginterferon alfa-2b trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Ropeginterferon alfa-2b an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Ropeginterferon alfa-2b or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.